Search

everythinglearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Mouse models help study genetic skin diseases.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

The platform effectively grows lung cancer cell spheroids for drug testing.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Different people show different symptoms for genetic diseases because of how sensitive their bodies are to small changes in important factors.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

The model effectively mimics radiation-induced skin damage for future research.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Mutations in the spike protein affect drug binding and effectiveness.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

A new mouse model for vitiligo helps study immune responses and potential treatments.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.